Improving Adherence to Adjuvant Hormonal Therapy Among Disadvantaged Women Diagnosed with Breast Cancer in South Carolina: Proposal for a Multimethod Study

BACKGROUND: Current clinical guidelines recommend that hormone receptor–positive breast cancer survivors take adjuvant hormonal therapy (AHT) for 5 to 10 years, following the end of definitive treatment. However, fewer than half of patients adhere to the guidelines, and suboptimal adherence to AHT i...

Descripción completa

Detalles Bibliográficos
Autores principales: Felder, Tisha M, Heiney, Sue P, Hebert, James R, Friedman, Daniela B, Elk, Ronit, Franco, Regina, Gansauer, Lucy, Christensen, Barbara, Ford, Marvella E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Proposal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499167/
https://www.ncbi.nlm.nih.gov/pubmed/32880374
http://dx.doi.org/10.2196/17742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499167/
https://www.ncbi.nlm.nih.gov/pubmed/32880374
http://dx.doi.org/10.2196/17742

Ejemplares similares